T1 ‐ T2 Interplay in the Complex Immune Landscape of Severe Asthma
Immunological Reviews · 2025-03 · 330 (1)
DOI: 10.1111/imr.70011 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunological Reviews, online erschienen am 24.02.2025. Verfasst von Marc Gauthier und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonary Allergy Critical Care and Sleep Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, US…. Hauptthemen laut MEDLINE: Asthma, Th2 Cells, T-Lymphocyte Subsets, Th1 Cells. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 162 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NHLBI NIH HHS, NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Asthma is orchestrated by an aberrant immune response involving a complex interplay between multiple inflammatory cell types. An increase in Th2 cells in the asthmatic airway is a hallmark of asthma, and biologics blocking their effector functions have been life‐changing for many severe asthma patients who poorly respond to immunosuppression by corticosteroids. However, studies in the past decade have highlighted not only other cell types that also produce Th2 cytokines boosting the Type 2/T2 phenotype but also a heightened IFN‐γ response, primarily from T cells, referred to as a Type 1/T1 immune response. Data derived from studies of immune cells in the airways and mouse models of severe asthma suggest a role of IFN‐γ in corticosteroid resistance, airway hyperreactivity, and also airway remodeling via effects on other cell types including mast cells, eosinophils, airway epithelial cells, and airway smooth muscle cells. The simultaneous presence of T1 and T2 immune responses is detectable in the sickest of asthma patients in whom corticosteroids suppress the T2 but not the T1 response. This article has reviewed our current understanding of the complex T1–T2 interplay in severe asthma highlighting mediators that impact both arms which may be targeted alone or in combination for disease alleviation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pulmonary Allergy Critical Care and Sleep Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
- Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
ORCID-Profile: Anuradha Ray
Förderung
- NHLBI NIH HHS
- NIH HHS
- NIAID NIH HHS
- National Institutes of Health
Zitieren
APA
Gauthier, M., Kale, S. L., & Ray, A. (2025). T1 ‐ T2 Interplay in the Complex Immune Landscape of Severe Asthma. Immunological Reviews, 330(1). https://doi.org/10.1111/imr.70011
Vancouver
Gauthier M, Kale SL, Ray A. T1 ‐ T2 Interplay in the Complex Immune Landscape of Severe Asthma. Immunological Reviews. 2025;330(1). doi:10.1111/imr.70011
BibTeX
@article{Gauthier2025,
author = {Gauthier, Marc and Kale, Sagar L and Ray, Anuradha},
title = {T1 ‐ T2 Interplay in the Complex Immune Landscape of Severe Asthma},
journal = {Immunological Reviews},
year = {2025},
volume = {330},
number = {1},
doi = {10.1111/imr.70011}
}
EUVIMED